$62.00
1.001.64%
At close: -
$59.35
-2.65-4.27%
After Hours: Apr 9, 9:29 AM EDT
As of Mar 31, 2025
iShares U.S. Pharmaceutical ETF (ARCA: IHE)
Ticker | Name | Share % | |
---|---|---|---|
JNJ | Johnson & Johnson | 22.46% | |
LLY | Eli Lilly & Co. | 22.17% | |
VTRS | Viatris | 4.16% | |
BMY | Bristol-Myers Squibb Co. | 4.50% | |
PFE | Pfizer, Inc. | 4.35% | |
ZTS | Zoetis Inc. [zts] | 4.49% | |
RPRX | Royalty Pharma | 4.18% | |
CTLT | Catalent, Inc. | 4.27% | |
MRK | Merck & Company Inc. | 4.24% | |
ITCI | Intra-Cellular Therapies Inc | 4.43% | |
JAZZ | Jazz Pharmaceuticals, Plc | 2.97% | |
CORT | Corcept Therapeutics Inc | 4.32% |
The IHE ETF is currently trading at $59.35, which represents a -2.70% change. Over the past 52 weeks, the ETF has traded as high as $73.28 and as low as $58.97.
The expense ratio of IHE is 0.39%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for IHE is 524.09M. This represents the total market value of the assets managed by the ETF.
IHE follows a Large Cap Blend investment style.
The top holdings of IHE include: JNJ (22.46%), LLY (22.17%), VTRS (4.16%), BMY (4.5%), PFE (4.35%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for IHE is currently not available.